To include your compound in the COVID-19 Resource Center, submit it here.

ARX788: Phase I started

Ambrx and Zhejiang began an open-label, Australian and New Zealand Phase I

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE